These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8257636

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of retrovirus-induced syncytium formation by photoproducts of a brominated 1,8-naphthalimide compound.
    Chanh TC, Lewis DE, Judy MM, Sogandares-Bernal F, Michalek GR, Utecht RE, Skiles H, Chang SC, Matthews JL.
    Antiviral Res; 1994 Oct; 25(2):133-46. PubMed ID: 7847875
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
    Konopka K, Pretzer E, Düzgünes N.
    Biochem Biophys Res Commun; 1995 Mar 08; 208(1):75-81. PubMed ID: 7887968
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine.
    Li BQ, Fu T, Yan YD, Baylor NW, Ruscetti FW, Kung HF.
    Cell Mol Biol Res; 1993 Mar 08; 39(2):119-24. PubMed ID: 7693133
    [Abstract] [Full Text] [Related]

  • 6. Effects of tubeimoside-1 on HIV core protein p24 and cytopathogenesis in vitro.
    Yu LJ, Ma RD, Jiang SB.
    Zhongguo Yao Li Xue Bao; 1994 Mar 08; 15(2):103-6. PubMed ID: 8010099
    [Abstract] [Full Text] [Related]

  • 7. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
    Konopka K, Pretzer E, Celada F, Düzgüneş N.
    J Gen Virol; 1995 Mar 08; 76 ( Pt 3)():669-79. PubMed ID: 7897355
    [Abstract] [Full Text] [Related]

  • 8. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW, Schols D, Pauwels R, De Clercq E, Meijer DK.
    Mol Pharmacol; 1993 Nov 08; 44(5):1003-7. PubMed ID: 7902528
    [Abstract] [Full Text] [Related]

  • 9. Effects of serotonin and melanin on in vitro HIV-1 infection.
    Sidibe S, Saal F, Rhodes-Feuillette A, Lagaye S, Pelicano L, Canivet M, Peries J, Dianoux L.
    J Biol Regul Homeost Agents; 1996 Nov 08; 10(1):19-24. PubMed ID: 9049777
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.
    Pal R, Mumbauer S, Hoke G, Larocca R, Myers C, Sarngadharan MG, Stein CA.
    AIDS Res Hum Retroviruses; 1991 Jun 08; 7(6):537-43. PubMed ID: 1718343
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N, Schols D, De Clercq E, Debyser Z, Pauwels R, Balzarini J, Nakashima H, Baba M, Hosoya M, Snoeck R.
    Mol Pharmacol; 1992 Dec 08; 42(6):1109-17. PubMed ID: 1282664
    [Abstract] [Full Text] [Related]

  • 13. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
    Fujihashi T, Sakata T, Kaji A, Kaji H.
    AIDS Res Hum Retroviruses; 1995 Apr 08; 11(4):461-71. PubMed ID: 7543270
    [Abstract] [Full Text] [Related]

  • 14. Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4.
    Watkins BA, Crowley R, Davis AE, Louie AT, Reitz MS.
    J Gen Virol; 1997 Oct 08; 78 ( Pt 10)():2513-22. PubMed ID: 9349472
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by daphnodorins.
    Yusa K, Oh-hara T, Tsukahara S, Baba K, Taniguchi M, Kozawa M, Takeuchi S, Hara H, Tsuruo T.
    Antiviral Res; 1994 Sep 08; 25(1):57-66. PubMed ID: 7529015
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Soluble CD4 and CD4 immunoglobulin-selected HIV-1 variants: a phenotypic characterization.
    Klasse PJ, McKeating JA.
    AIDS Res Hum Retroviruses; 1993 Jul 08; 9(7):595-604. PubMed ID: 8369164
    [Abstract] [Full Text] [Related]

  • 19. Continuous presence of CD4-PE40 is required for antiviral activity against single-passage HIV isolates and infected peripheral blood mononuclear cells.
    Winters MA, Merigan TC.
    AIDS Res Hum Retroviruses; 1993 Nov 08; 9(11):1091-6. PubMed ID: 8312052
    [Abstract] [Full Text] [Related]

  • 20. Calmodulin antagonists inhibit human immunodeficiency virus-induced cell fusion but not virus replication.
    Srinivas RV, Bernstein H, Oliver C, Compans RW.
    AIDS Res Hum Retroviruses; 1994 Nov 08; 10(11):1489-96. PubMed ID: 7888203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.